Conexeu Sciences, Inc. (CNXU)
3.90
+0.45
(+13.04%)
USD |
NASDAQ |
Oct 09, 16:00
3.86
-0.04
(-1.03%)
After-Hours: 20:00
Conexeu Sciences EPS Diluted (Quarterly) : -0.282 for July 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -0.282 |
| April 30, 2026 | -0.0861 |
| January 31, 2026 | 0.00 |
| Date | Value |
|---|---|
| October 31, 2025 | -0.0897 |
| April 30, 2025 | -0.0171 |
| October 31, 2024 | -0.0052 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 2.033 |
| Vericel Corp. | 0.0422 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.726M |
| Total Expenses (Quarterly) | 7.726M |
| Enterprise Value | 92.38M |
| Earnings Yield | -11.74% |